Allay Therapeutics Funding: $60M Raised, Series C (2021)
Allay Therapeutics is based in San Jose, CA. It has raised $60M in total funding. Latest round: Series C.
Allay Therapeutics funding overview
Allay Therapeutics is based in San Jose, CA. Allay Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2021. The round record for Allay Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Arboretum Ventures, Brandon Capital Partners, New Enterprise Associates, Pavilion Capital Partners, Temasek Holdings, Vertex Growth and 2 others. 8 distinct backers are named across the disclosed rounds.
Allay Therapeutics at a glance
Total raised
$60M
Latest round
Series C
Latest round date
September 2021
Headquarters
San Jose, CA
Notable investors
Arboretum Ventures, Brandon Capital Partners, New Enterprise Associates, Pavilion Capital Partners, Temasek Holdings, Vertex Growth, Vertex Ventures HC, WTT Investment
Frequently asked about Allay Therapeutics funding
How much has Allay Therapeutics raised?
Allay Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Allay Therapeutics?
Arboretum Ventures, Brandon Capital Partners, New Enterprise Associates, Pavilion Capital Partners, Temasek Holdings, Vertex Growth are named among the investors backing Allay Therapeutics.
What was the latest Allay Therapeutics funding round?
The most recent disclosed round is a Series C, announced in September 2021.
Where is Allay Therapeutics based?
Allay Therapeutics is based in San Jose, CA.
When did Allay Therapeutics last raise?
The last disclosed Allay Therapeutics round closed in September 2021 at Series C.
We update the Allay Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Jose and their backers are listed below.
